ArticleScientific reports2026
Research on improved models for facial expression recognition in mice with abnormal glucose metabolism.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study explores the intervention effect of Sparassis Latifolia Polysaccharides (SLPs) on abnormal glucose metabolism in C57BL/6J mice, induced by a high-fat diet and streptozotocin (STZ). The results show that high-concentration SLPs significantly improve abnormal glucose metabolism. A mouse facial expression dataset was constructed, covering five glucose metabolic states: Norm, Pre-stage of Abnormal Glucose Metabolism, Abnormal Glucose Metabolism, Early Stage of SLPs Intervention, and Late Stage of SLPs Intervention, based on fasting blood glucose and facial expression features. To achieve non-invasive detection of abnormal glucose metabolism, a lightweight deep learning model, LFPP-YOLO, was proposed. This model incorporates a Partial Self-Attention (PSA) module to enhance global context information extraction and utilizes the L-FFCA structure for multi-level feature enhancement and background suppression, improving its adaptability to complex expressions. The PIoU v2 loss function was employed to optimize facial expression localization accuracy and robustness. Experimental results show that the LFPP-YOLO model achieves an average facial detection accuracy of 95.1% across the five metabolic states, with a compact size of 2.4 MB and a real-time inference speed of 5ms, significantly outperforming existing models. This model provides a novel approach and technical support for non-invasive screening and personalized intervention of abnormal glucose metabolism in mice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.